On the contrary, a recent study found that, although exenatide intervention could improve lipid deposition and insulin sensitivity in ob/ob mice (leptin-deficient obese T2DM mice model), it failed to reduce body weight (Xu et al. 2020). The gene discussed is LEP; the disease is type 2 diabetes mellitus.